Forte Biosciences, Inc.

NASDAQ:FBRX

Biotechnology

Healthcare
$76.99 +1.71%

+$0.30 today

Market cap
$1.58B
Beta
2.87
P/E (TTM)
-42.1
EPS (TTM)
-$0.43
52W Low $9.10High $35.80

Volume 0.00M

Average 0.30M

FBRX EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

Forte Biosciences, Inc.NASDAQ: FBRX

EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026

EPS (Basic) remains negative

Q1 FY2026 EPS (Basic) was -$1.24, compared with -$1.37 a year earlier. Trailing-twelve-month EPS (Basic) was -$4.58.

Context

  • EPS (Basic) grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether EPS (Basic) reaches the consensus estimate from 4 analysts of -$4.11 (+12.8%) for the fiscal year ending Dec 2026, a slowdown from the +61.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.24+10.8% QoQ
Last fiscal yearDec 2025
-$4.71+61.3% YoY
LTMMar 2026
-$4.58+66.8% YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+9.5%-7.3%-16.8 pp
1 year+61.3%+12.8%-48.5 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Basic) history

USD · from the income statement

Latest · FY2025
(4.71) USD
Year-over-year change
+61.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Basic) vs competitors

How FBRX compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +66.8% is the highest of 10, against a peer median of +26.8%.
FBRX Competitors
EPS (Basic) for FBRX and competitors
Company Period LTM YoY 3-year CAGR
CRDFCardiff Oncology, Inc.LTM Mar 2026-$0.67 USD+30.2%—
ACTUActuate Therapeutics IncLTM Mar 2026-$0.99 USD+45.3%—
FATEFate Therapeutics, Inc.LTM Mar 2026-$1.09 USD+26.8%—
ALECAlector, Inc.LTM Mar 2026-$1.19 USD+6.4%—
NKTXNkarta, Inc.LTM Mar 2026-$1.34 USD+11.3%—
MOLNMolecular Partners AGLTM Mar 2026-CHF 1.56 CHF+9.3%—
PEPGPepGen Inc.LTM Mar 2026-$1.94 USD+38.0%—
ELTXElicio Therapeutics, Inc.LTM Mar 2026-$2.36 USD+41.7%—
FBRXForte Biosciences, Inc.LTM Mar 2026-$4.58 USD+66.8%—
CRBPCorbus Pharmaceuticals Holdings, Inc.LTM Mar 2026-$6.6 USD+3.9%—
Peer median (excluding FBRX) —+26.8%—

Competitors are the stored peer set for FBRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue36K09K39K64K
Gross Profit(36K)0(9K)(39K)(64K)
Gross Margin—————
Research & Development13.85M5.59M21.86M21.19M58.25M
Selling, General & Admin7.63M8.3M10.62M15.37M12.41M
Operating Expenses21.49M13.9M32.48M36.56M70.66M
Depreciation & Amortization36K36K9K39K64K
EBITDA(21.67M)(13.84M)(31.47M)(35.44M)(68.27M)
EBITDA Margin—————
Operating Income(21.49M)(13.9M)(32.49M)(36.6M)(70.66M)
Operating Margin—————
Interest Income001.12M1.31M2.72M
Interest Expense00000
Other Income / Expenses(222K)17K1.01M1.12M2.32M
Income Before Tax(21.71M)(13.88M)(31.48M)(35.48M)(68.34M)
Pre-Tax Margin—————
Income Tax Expense00001.04M
Net Income(21.71M)(13.86M)(31.48M)(35.48M)(69.38M)
Net Margin—————
EPS (Basic)(38.85)(19.96)(24.92)(12.17)(4.71)
EPS (Diluted)(38.85)(19.96)(24.92)(12.17)(4.71)
Weighted Avg Shares558.71K695.34K1.26M2.92M147.18M
Weighted Avg Shares (Diluted)558.71K695.34K1.26M2.92M147.18M

Forte Biosciences, Inc.

NASDAQ:FBRX

Intrinsic Alpha fair value

Locked

Current Price

$76.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.